Current Events

The FDA has updated its list of blood pressure medications that are being recalled after traces of a cancer-causing ingredient were found in several batches.

The agency last month said it was recalling valsartan tablets made in China after tests showed some contained Nitrosodimethylamine, or NDMA,  a probable carcinogen.

Read More

Monsanto Co. was socked with $289 million in damages in the first trial over claims that its Roundup weed killer causes cancer.

Lee Johnson, a former school groundskeeper whose doctors didn’t think he’d live long enough learn the verdict, prevailed Friday in San Francisco state court after jurors deliberated for three days. The trial was an important test of the evidence against Monsanto and will serve as a template for litigating thousands of other claims over the herbicide.

Johnson was seeking $412 million in damages.
Read more . . .

GOSHEN — Nurses picketed, state Department of Health inspectors swarmed, and complaints streamed to local elected leaders and the Times Herald-Record in the months after for-profit owners bought the former Elant nursing home in Goshen.

Now, nearly a year after the home became Sapphire Nursing and Rehab at Goshen, a Westchester law firm has filed a scathing lawsuit against the business, and the attorneys are seeking class-action status.

The plaintiffs, a current resident of the home and the estate of a deceased resident, accuse the owners of slashing staff so deeply that residents often sat in their own waste, begging visitors for bathroom help, meals and care.

The suit seeks monetary damages, but also asks the court to require the home to provide proper care.

Sapphire’s troubles under its new leadership reflect a larger trend, according to nursing home experts.
Read more . . .

Bayer announced it would stop selling its Essure birth control device at the end of 2018. It’s the end of the device in the U.S., but it may only be the beginning of more controversy surrounding the implant.

Bayer insists its decision to discontinue Essure was a financial decision.
Read more . . .

The first man died in April 2014. Another died later that month. Then on July 18 of that year, a woman was rushed to a hospital where she was told she was lucky to be alive.

They all went to the same Little Rock, Ark., surgery center for a colonoscopy, among the safest procedures a patient can have.
Read more . . .

That poorly ventilated conference room isn’t the only place with the potential for sick-air syndrome.

Airliner cockpits can also have levels of carbon dioxide elevated enough that in simulations it causes pilots to fail test maneuvers at higher rates than normal, a new Harvard University study has found.

The first-of-its-kind research suggests that current regulations aren’t adequate to assure there’s enough fresh air in airline flight decks and raises questions about whether even moderately elevated carbon dioxide levels could impact safety, said Joseph Allen, an assistant professor at Harvard’s School of Public Health and lead author of the study.

Read more . . .

(Reuters) - Insys Therapeutics said on Wednesday it had reached a deal to pay at least $150 million to resolve a U.S. Justice Department investigation into claims that the drugmaker paid doctors kickbacks to prescribe a powerful opioid medication.

Insys announced the tentative deal shortly before a former district sales manager pleaded guilty in a federal court in Connecticut to engaging in a scheme to pay medical practitioners kickbacks to prescribe the company’s opioid product Subsys.

Read more . . .

AstraZeneca agreed to pay $110 million to settle two lawsuits in the US claiming that the company fraudulently marketed Seroquel (quetiapine) and Crestor (rosuvastatin). "While we deny the allegations, it is in the best interests of the company to resolve these matters…while avoiding the delay, uncertainty and expense of protracted litigation," the drugmaker said.

Under the settlements with the state of Texas, AstraZeneca will pay $90 million to resolve allegations that the company encouraged doctors to use Seroquel for unapproved uses and $20 million to cover claims related to Crestor. Texas had sought $5 billion under the lawsuits, claiming that AstraZeneca had falsely and misleadingly marketed the two drugs.

Read more . . .

A popular drug used to treat high blood pressure has been recalled because some products may contain a cancer-causing chemical.

In an ongoing investigation, the Food & Drug Administration has expanded the swath of the recall of the drug valsartan, which is used to treat high blood pressure and heart failure. The recalled drugs, manufactured by Zhejiang Huahai Pharmaceuticals in Linhai, China, contain the chemical N-nitrosodimethylamine, or NDMA, which has been found to cause cancer in humans based on laboratory studies, the agency says.

Last month, the FDA issued a voluntary recall for some valsartan tablets and has since expanded it twice to include additional products from more drug companies, as well as some tablets with valsartan and hydrochlorothisazide (HCTZ).

Read more . . .

Some 395 people have become sick from eating tainted McDonald's salads, according to an updated count from the Centers for Disease Control and Prevention.

The illnesses have been linked to salad mix contaminated with the Cyclospora parasite, which is spread through fecal matter. Sixteen individuals have been hospitalized, according to the CDC.

Fifteen states have confirmed cases, primarily in the Midwest. Illinois, where McDonald's is headquartered, has the most: 202.
Read more . . .

A proposed class action filed on Thursday accuses New York state of improperly denying medically necessary dental care to thousands of residents eligible for Medicaid coverage by banning or restricting certain services such as dental implants.

Two New York residents who were denied coverage for dental care and who are represented by the Legal Aid Society filed the lawsuit in federal court in Manhattan seeking an order barring the state from continuing to restrict coverage.

Read More